177Lu-FAP-2286 Therapy in a Metastatic Bone Malignant Solitary Fibrous Tumor
Yang Hong-yu, Huipan Liu, Hongmei Li, Yu Zhang, Yue Chen
Abstract
ABSTRACT: A 57-year-old woman with a metastatic bone malignant solitary fibrous tumor received 177 Lu-FAP-2286 therapy. After 1 treatment cycle, 68 Ga-FAP-2286 PET/CT revealed remission of the lesions. Moreover, the patient did not report any adverse effects.
Topics & Concepts
MedicineSolitary fibrous tumorRadiologyStem cellCD34GeneticsBiologyPeptidase Inhibition and AnalysisSoft tissue tumor case studiesMedical Imaging and Pathology Studies